Ubiqam Ltd.
USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04B (Transmission).
The verdict
According to USPTO PatentsView, Ubiqam ranks #43,801 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 3 technology areas.
- #43,801
- of 49,997 US assignees by volume
- 46th percentile
- by Innovation Score (34.0/100)
- 24.2
- avg claims per patent
- -50%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R43801 · Foreign Corporation #43,801 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #43,801/49,997
- PHOTO-FINISH Ultimovacs ASA
- CPC-NARROW H04B · 3 areas
- INNOV-THIN 34.0/100
- CLAIMS-DENSE 24.2 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -50% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Ultimovacs ASA (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Ubiqam’s 34.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Ubiqam
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Ubiqam · this assignee 34
Ubiqam · this assignee
34 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Ubiqam's Innovation Score is 34.0/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Ubiqam?
Each dot is one of Ubiqam’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ubiqam’s own 24.2 claims/patent is ABOVE the 15.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Ubiqam's grants concentrate
Ubiqam Ltd. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under H04B (Transmission). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2016. By volume, Ubiqam sits between Utah-inha DDS & Advanced Therapeutics Research CEN and Unified Office, Inc..
Ubiqam's three-year grant acceleration
Ubiqam Ltd. shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Ubiqam's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Utah-inha DDS & A…
Utah-inha DDS & Advanced Therapeutics Research CEN
6 patents
- UTC Fire & Securi…
UTC Fire & Security Emea Bvba
6 patents
- Utilization Techn…
Utilization Technology Development, NFP
6 patents
- UV Innovators
UV Innovators, LLC
6 patents
- Ultimovacs ASA
Ultimovacs ASA
6 patents
- Ultrasonix Medical
Ultrasonix Medical Corporation
6 patents
- Umeheal
Umeheal Ltd.
6 patents
- Unified Office
Unified Office, Inc.
6 patents
- Ubiqam ◀
Ubiqam Ltd.
6 patents
What this shows Ubiqam holds 6 patents at rank #43,816, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Ubiqam
By rank, the assignees closest to #43,816 in granted patent volume.
- Utah-inha DDS & Advanced Therapeutics Research CEN #43,812 · 6 patents
- UTC Fire & Security Emea Bvba #43,813 · 6 patents
- Utilization Technology Development, NFP #43,814 · 6 patents
- UV Innovators, LLC #43,815 · 6 patents
- Ultimovacs ASA #43,817 · 6 patents
- Ultrasonix Medical Corporation #43,818 · 6 patents
- Umeheal Ltd. #43,819 · 6 patents
- Unified Office, Inc. #43,820 · 6 patents
Leaders in H04B (Transmission)
Other assignees with the most granted patents in Ubiqam's primary technology class.
- Qualcomm Incorporated 6,670 in class
- Samsung Electronics Co., Ltd. 4,632 in class
- LG Electronics Inc. 3,654 in class
- Huawei Technologies Co., Ltd. 3,555 in class
- Telefonaktiebolaget LM Ericsson (Publ) 3,146 in class
- Apple Inc. 2,286 in class
- Intel Corporation 1,705 in class
- Sony Group Corporation 1,475 in class
Ubiqam's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
34 46th percentile higher than 46% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 33.3% |
| 2016 | 1 | 16.7% |
| 2018 | 1 | 16.7% |
| 2021 | 1 | 16.7% |
| 2022 | 1 | 16.7% |
Which technologies does Ubiqam Ltd. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Ubiqam Ltd.'s patent record in context - here's where to go next.
- Ubiqam Ltd.'s lead technology class is H04B (Transmission), 100% of its portfolio - see every assignee active in that class. Explore H04B
- Ranked #43,801 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Ubiqam Ltd. against Utah-inha DDS & Advanced Therapeutics Research CEN, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 34.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.